SynthesisFrontiers in psychology2025
Prevalence of stigma among patients with schizophrenia: a multi-country systematic review and meta-analysis.
Synthesis in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to systematically assess the current prevalence of stigma experienced by individuals with schizophrenia and to provide evidence that can inform the development of effective intervention strategies. Methods: A systematic search was conducted in PubMed, Embase, Ovid, Web of Science, Cochrane Library, CINAHL, CNKI, Wanfang, VIP, and CBM databases to identify studies on stigma in schizophrenia patients from their inception up to November 2024. Two independent researchers performed literature screening, data extraction, and quality assessment. Meta-analysis was carried out using Stata 17.0. Results: Fourteen studies encompassing a total of 1,872 schizophrenia patients were included in the analysis. The pooled prevalence of stigma was 75.3% (95 Conclusion: The prevalence of stigma among individuals with schizophrenia is substantial and influenced by region, assessment instruments, age, stage of illness, and sample size. The subgroup analysis indicated a higher prevalence of stigma associated with the following factors: studies conducted in Asia, the use of the PPD scale, publication after 2018, participants aged > 60 years, Sample size: ≤ 200 cases and patients in the remission stage. Future efforts should prioritize developing culturally adapted interventions specifically aimed at reducing stigma, enhancing social functioning, and improving patients' quality of life. Systematic review registration: PROSPERO, identifier: CRD42024590215.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.